Re: How much damage was done to the 336 during re-exams? Did we lose the right to

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: How much damage was done to the 336 during re-exams? Did we lose the right to

in response to

Re: How much damage was done to the 336 during re-exams? Did we lose the right to

emit

posted on Sep 12, 2010 04:57PM

<Didn't the PR state this: ''The United States Patent and Trademark Office (USPTO) has issued a Notice of Intent to Issue Reexamination Certificate for the US'336 patent indicating that all claims will be allowed with no amendments to the claim language."

If you are referring to the second NIRC of the most recent reexam, yes. If you are referring to the prior reexam, no.

<"Not only have the majority of original claims in this patent survived, but it has been further strengthened by the addition of new claims. This represents an important victory for the MMP Portfolio.">

Surviving is different from being unamended. No argument that new claims strengthened the patent.